Concepedia

Xiang Xu

XX

Statistics

Publications

8

Citations

366

H-Index

8

Active since

2014

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Shanghai First People's Hospital

Shanghai Jiao Tong University

East China University of Science and Technology

Xiang Xu is an author at Dana-Farber Cancer Institute specializing in molecular biology, drug design, and drug discovery.

ORCID

Publications per year

2014–2023

8

Publications

8

Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors

Michael R. McKeown, Daniel L Shaw, Harry Fu et al. · Journal of Medicinal Chemistry · 2014 · 93 citations · Full text

, , +14

Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2

Jonathan R. LaRochelle, Michelle Fodor, Xiang Xu et al. · Biochemistry · 2016 · 72 citations · Full text

, , +17

Structure of human POFUT1, its requirement in ligand-independent oncogenic Notch signaling, and functional effects of Dowling-Degos mutations

Brian J. McMillan, Brandon Zimmerman, Emily D. Egan et al. · Glycobiology · 2017 · 46 citations · Full text

, , +14

Calcium channel TRPV6 promotes breast cancer metastasis by NFATC2IP

Xiang Xu, Na Li, Yugang Wang et al. · Cancer Letters · 2021 · 43 citations

, , +14

TRPA1 channel mediates organophosphate-induced delayed neuropathy

Qiang Ding, Sui Fang, Xueqin Chen et al. · Cell Discovery · 2017 · 40 citations · Full text

, , +17

1–5 of 8